Clinical and economic burden of infused iron chelation therapy in the United States
✍ Scribed by Krista A. Payne; Marie-Pierre Desrosiers; J. Jaime Caro; Jean-François Baladi; Noreen Lordan; Irina Proskorovsky; Khajak Ishak; Diana Rofail
- Book ID
- 109143782
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 250 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0372-1248
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
According to the third National Health and Nutrition Examination Survey (NHANES), 3.9 million of the U.S. civilian population have been infected with hepatitis C virus (HCV), of whom 2.7 million (74%) have chronic infection. Hepatitis C virus infection is most common among non-Caucasian men, ages 30
## Abstract ## BACKGROUND Mucositis is a common but poorly studied problem among patients with solid tumors. The authors examined the clinical and economic outcomes of oral and gastrointestinal (GI) mucositis among patients receiving myelosuppressive chemotherapy. ## METHODS A retrospective, ran
## The Burdens of Cancer Therapy Clinical and Economic Outcomes of Chemotherapy-Induced Mucositis W e read with great interest the article by Elting et al. describing the clinical and economic outcomes of patients with chemotherapyinduced mucositis. 1 Despite the limitation of a retrospective anal